InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,419.20
(
0.00%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.55
(
0.51%
)
Bitcoin
64,474.44
(
0.74%
)
Post# of 14671
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

fishypete

Send PM Follow Ignore
Followers 0
Posts 337
Boards Moderated 0
Alias Born 03/20/2002

fishypete

Re: None

Wednesday, 05/29/2002 9:21:47 AM

Wednesday, May 29, 2002 9:21:47 AM

Post# of 14671
BioShield Technologies Highlighted in BusinessWeek Magazine With AbTech



RELATED SYMBOLS: (BSTI)

ATLANTA, May 29, 2002 /PRNewswire-FirstCall via COMTEX/ -- BioShield
Technologies, Inc. (OTC Bulletin Board: BSTI) announced the Company was part of
an exclusive profile of specific companies in BusinessWeek's Developments to
Watch section of the May 27, 2002 issue.

In the article titled Developments to Watch -- Making Storm Drains the Last Stop
for Toxins, BioShield, along with its licensee partner, AbTech Industries, was
discussed as one of the new leading companies providing a remedy that filters
out the toxins, oils, grease and PCB's before they flow downstream, potentially
threatening fresh water and water bodies which pose a significant health
concern. The article further mentions that three states are testing the
antibacterial filter kits.

ABOUT BIOSHIELD:

BioShield Technologies, Inc., is a Georgia-based biotechnology and antimicrobial
products company. Its core business is committed to the discovery, development,
marketing and sale of surface-modifying antimicrobial and biostatic products.
The company's antimicrobial technology is a revolutionary alternative to
conventional sanitizers, disinfectants, bleaches, biocides or preservatives
primarily because it kills bacteria, including HIV and eColi, on contact and can
remain active for extended time periods. To date, BioShield has received three
US patents and eight EPA registrations, including the first U.S. germ killer and
disinfectant against Salmonella cholerasuis, Staphylococcus aureus and other
microorganisms. The company has developed several alliances in different
industries, such as healthcare, textiles and storm water.

ABOUT BIOSHIELD'S TECHNOLOGY:

BioShield began researching and developing antimicrobial technology in 1995.
BioShield began receiving patents on its technology in 1999, under U.S. Pat.
5,954,869. In September 2000, two additional patents, U.S. Pat. Number 6120587
and 6113815, were issued. Other patents, filed in several countries in the
European Community, as well as Brazil, Israel, Mexico, Japan and New Zealand are
pending. Using a proprietary stabilizer with the active ingredient, BioShield's
antimicrobial products deliver all the traditional benefits associated with an
organosilane, however do not posses the toxic hazards. BioShield's proprietary
technology is a durable antimicrobial shield that protects surfaces from
microbial deterioration by inhibiting microbial growth. At the same time,
BioShield's technology is safer to handle than conventional-based additives,
doesn't require special equipment, and readily delivers silane-to-surface bonds
from water-stable solutions. BioShield's patented antimicrobial technology is a
residual antimicrobial molecule approved by the E.P.A. with eight registrations
in effect for multiple consumer and industrial uses. The company's active
molecule has the unique ability to bind itself to hundreds of types of surfaces
thus creating essentially a new surface that is protected and inhibits the
growth of bacteria for extended periods of time that typically help stop cross-
contamination. The Environmental Protection Agency (E.P.A.) currently approves
BioShield's technology for fogging in institutional and industrial facilities
and homeowner dwellings. The application can be simply sprayed on surfaces,
washed into clothing or bonded to a multitude of fabrics and finished coatings.

Further information on BioShield and its line of products can be found by
visiting the firm's web site at http://www.bioshield.com or by calling Tim Moses
at 1-770-925-3653.

Safe Harbor/Forward-looking Statements:

Statements in this news release that are not historical are forward- looking
statements. These forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from those
anticipated in any forward-looking statements, all of which are difficult to
predict and many of which are beyond the control of the company, including areas
such as: developing technologies; dependence on collaborative partners; the
inherent complexity and uncertainty regarding the development of products;
early-stage development of BioShield the result of research and development
efforts; future capital needs; uncertainty of additional funding; government
regulations; and other factors which are detailed in the company's periodic
reports and registration statements filed with the Securities and Exchange
Commission. BioShield does not undertake to revise or update any forward-looking
statement to reflect events or circumstances that may arise after the date
hereof. BioShield is a trademark of BioShield, Technologies, Inc.


MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X12074622

SOURCE BioShield Technologies, Inc.


CONTACT: Tim Moses of BioShield Technologies, Inc., +1-770-925-3653

URL: http://www.bioshield.com
http://www.prnewswire.com

Copyright (C) 2002 PR Newswire. All rights reserved.

-0-


KEYWORD: Georgia
INDUSTRY KEYWORD: CHM
BIO
OTC
PUB
ENV
MAG

(Wall Street)




Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up